tiprankstipranks
Advertisement
Advertisement

INM Stock Latest News

InMed Pharmaceuticals Announces Reverse Merger with Mentari Therapeutics
Company AnnouncementsInMed Pharmaceuticals Announces Reverse Merger with Mentari Therapeutics
11d ago
8K
INM
InMed Pharmaceuticals and Mentari announce merger for migraine prevention
PremiumThe Fly
InMed Pharmaceuticals and Mentari announce merger for migraine prevention
12d ago
INM
InMed Pharmaceuticals amends preferred investment options
PremiumThe Fly
InMed Pharmaceuticals amends preferred investment options
12d ago
INM
InMed Pharmaceuticals Lowers Exercise Price on Preferred Options
PremiumCompany Announcements
InMed Pharmaceuticals Lowers Exercise Price on Preferred Options
12d ago
8K
INM
InMed Highlights INM-901 Alzheimer’s Data in Q3 Update
PremiumCompany Announcements
InMed Highlights INM-901 Alzheimer’s Data in Q3 Update
24d ago
8K
INM
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
PremiumCompany AnnouncementsInMed Pharmaceuticals Reprices Investment Options to Attract Capital
1M ago
8K
INM
InMed Pharmaceuticals Announces ATM Offering Prospectus Filing
Premium
Company Announcements
InMed Pharmaceuticals Announces ATM Offering Prospectus Filing
2M ago
8K
INM
InMed Pharmaceuticals Faces Nasdaq Minimum Bid Price Noncompliance
Premium
Company Announcements
InMed Pharmaceuticals Faces Nasdaq Minimum Bid Price Noncompliance
2M ago
8K
INM
InMed receives Nasdaq notification regarding minimum bid price compliance
PremiumThe Fly
InMed receives Nasdaq notification regarding minimum bid price compliance
2M ago
INM
InMed warned by Nasdaq over minimum bid price non-compliance
PremiumCompany Announcements
InMed warned by Nasdaq over minimum bid price non-compliance
2M ago
INM
InMed Reports Positive Preclinical Data for Alzheimer’s Candidate
PremiumCompany Announcements
InMed Reports Positive Preclinical Data for Alzheimer’s Candidate
2M ago
8K
INM
InMed Pharmaceuticals announces preclinical data on effects of INM-901
PremiumThe Fly
InMed Pharmaceuticals announces preclinical data on effects of INM-901
2M ago
INM
InMed Pharmaceuticals files $50M mixed securities shelf
PremiumThe FlyInMed Pharmaceuticals files $50M mixed securities shelf
2M ago
INM
InMed outlines 2026 development plans for lead programs
Premium
Company Announcements
InMed outlines 2026 development plans for lead programs
3M ago
8K
INM
InMed Pharmaceuticals provides development outlook for 2026
Premium
The Fly
InMed Pharmaceuticals provides development outlook for 2026
3M ago
INM
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
PremiumCompany Announcements
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
3M ago
8K
INM
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
PremiumCompany Announcements
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
4M ago
8K
INM
InMed Shareholders Approve Directors and Equity Financing Flexibility
PremiumCompany Announcements
InMed Shareholders Approve Directors and Equity Financing Flexibility
5M ago
8K
INM
InMed Faces Challenges from New U.S. Legislation
PremiumCompany Announcements
InMed Faces Challenges from New U.S. Legislation
6M ago
8K
INM
InMed Pharmaceuticals Completes Key Study for INM-901
PremiumCompany AnnouncementsInMed Pharmaceuticals Completes Key Study for INM-901
6M ago
8K
INM
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
Premium
The Fly
InMed announces completion of pharmacokinetic studies for Alzheimer’s candidate
6M ago
INM
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
Premium
Company Announcements
InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901
6M ago
INM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >